Surgery Partners Inc.

SGRY | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.07

+$0.41 (+3.00%)

Sep 22, 2026, 10:41 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.79B

Enterprise Value $5.59B

Beta 1.92

Average Volume 1.79M

Shares Outstanding (Diluted) 128.83M

Shares Change YoY 1.45%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US86881A1007

Price Performance

Price Change 1M -5.7%

Price Change 3M -6.0%

Price Change 6M 13.4%

Price Change YTD -10.5%

Price Change 1Y -37.5%

Price Change 3Y -54.5%

Price Change 5Y -67.5%

1M CAGR (ann.) -12.0%

1Y CAGR (ann.) -38.0%

5Y CAGR (ann.) -22.1%

All-Time CAGR -3.0%

Valuation

PE Ratio -19.80

Forward PE 27.92

PEG Ratio -0.50

Forward PEG -1.31

PS Ratio 0.53

Forward PS 0.50

PB Ratio 1.07

P/FCF Ratio 9.52

P/Adj. FCF Ratio 9.54

P/OCF Ratio 6.83

EV/Sales 1.66

EV/EBIT 7.25

EV/EBITDA 5.90

EV/FCF 29.78

Earnings Yield -5.0%

FCF Yield 10.5%

Adj. FCF Yield 10.5%

Financial Health

Net Debt $3.53B

Total Debt $4.02B

Cash & Short-Term Investments $216.7M

Total Assets $8.05B

Current Ratio 1.95

Quick Ratio 1.78

Debt / Equity Ratio 2.40

Debt / EBITDA 4.24

Debt / FCF 21.42

OCF / Debt 0.06

Interest Coverage 0.60

Altman Z-Score 0.88

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 21.4%

Operating Profit Margin 11.9%

EBITDA Margin 28.1%

Net Profit Margin -2.6%

FCF Margin 5.6%

Adj. FCF Margin 5.6%

SBC / Revenue 0.0%

SBC Impact (per share) -0.2%

Returns

Return on Assets -1.1%

Return on Equity -5.2%

Return on Invested Capital 4.4%

Return on Capital Employed 5.4%

Return on Tangible Assets -3.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 8.2%

Revenue CAGR 5Y 9.9%

Revenue CAGR 10Y 12.3%

EPS CAGR 3Y -26.4%

EPS CAGR 5Y -37.1%

EPS CAGR 10Y 9.1%

FCF CAGR 3Y 36.7%

FCF CAGR 5Y 38.1%

FCF CAGR 10Y 8.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 22

EPS Growth Next 3Y 60.4%

Revenue Growth Next 3Y 2.3%

Earnings Date Nov 8, 2026

EPS Estimate (next Q) $0.10

EPS Growth Est (next Q) -23.1%

Revenue Est (next Q) $848.48M

Revenue Growth Est (next Q) 3.3%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $18

Price Target Upside 31.8%

Cash Flow

Operating Cash Flow $258M

Free Cash Flow $187.6M

Adj. Free Cash Flow $187.2M

FCF Per Share $1.46

OCF Per Share $2

OCF/S Ratio 7.7%

Income Statement

Revenue $3.37B

Gross Profit $719.4M

Operating Income $400.4M

EBITDA $947.6M

Net Income $-88.6M

EPS (Diluted) -$0.69

Revenue / Employee $210.39K

Profit / Employee $-5.54K

Employees 16,000